Skin Cancer Market Research Report-  Asia Pacific Forecast till 2030

Skin Cancer Market Information: By Type (Basal Cell Carcinoma, Squamous Cell Carcinoma), Treatment (Non-Invasive, Chemotherapy, Surgical), End Users (Hospital and Clinics, Diagnostic Centers, Cancer Research Institute) - Asia Pacific Forecasted till 2030

ID: MRFR/Pharma/0667-HCR | December, 2022 | Region : Global

Table of Contents

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Asia Pacific Skin Cancer Market, by Type

6.1 Introduction

6.2 Basal Cell Carcinoma

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Squamous-Cell Carcinoma

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Melanoma

6.4.1 Market Estimates & Forecast, 2020-2027

7. Asia Pacific Skin Cancer Market, by Treatment

7.1 Introduction

7.2 Non-Invasive Treatments

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Chemotherapy

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Surgical

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Others

8. Asia Pacific Skin Cancer Market, by End user

8.1 Introduction

8.2 Hospital and Clinics

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostic Centres

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Cancer Research Institute

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Others

9. Asia Pacific Skin Cancer Market, by Region

9.1 Introduction

9.2 Asia Pacific

9.2.1 Australia

9.2.2 Japan

9.2.3 China

9.2.4 India

9.2.5 Republic of Korea

9.2.6 Rest of Asia Pacific

10 Competitive Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Novartis International AG

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Sun Pharma Industries Ltd.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Elekta AB

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Varian Medical Systems Inc

11.5.1 Company Overview

11.5.2 Product/Business Segment Overview

11.5.3 Financial Overview

11.5.4 Key Development

11.5.5 SWOT Analysis

11.6 Eli Lilly and Co.

11.6.1 Company Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Overview

11.6.4 Key Development

11.6.5 SWOT Analysis

11.7 Bristol Myers Squibb

11.7.1 Company Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Overview

11.7.4 Key Development

11.7.5 SWOT Analysis

11.8 Leo Pharma A/S

11.8.1 Company Overview

11.8.2 Product/Business Segment Overview

11.8.3 Financial Overview

11.8.4 Key Development

11.8.5 SWOT Analysis

11.9 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix

 

LIST OF TABLES

Table 1 Skin Cancer Industry Synopsis, 2020-2027

Table 2 Asia Pacific Skin Cancer Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Asia Pacific Skin Cancer Market by Country, 2020-2027, (USD Million)

Table 4 Asia Pacific Skin Cancer Market by Types, 2020-2027, (USD Million)

Table 5 Asia Pacific Skin Cancer Market by Treatment, 2020-2027, (USD Million)

Table 7 Asia Pacific Skin Cancer Market by End Users, 2020-2027, (USD Million)

Table 8 Australia Skin Cancer Market by Types, 2020-2027, (USD Million)

Table 9 Australia Skin Cancer Market by Treatment, 2020-2027, (USD Million)

Table 10 Australia Skin Cancer Market by End Users, 2020-2027, (USD Million)

Table 11 Japan Skin Cancer Market by Types, 2020-2027, (USD Million)

Table 12 Japan Skin Cancer Market by Treatment, 2020-2027, (USD Million)

Table 13 Japan Skin Cancer Market by End Users, 2020-2027, (USD Million)

Table 14 China Skin Cancer Market by Types, 2020-2027, (USD Million)

Table 15 China Skin Cancer Market by Treatment, 2020-2027, (USD Million)

Table 16 China Skin Cancer Market by End Users, 2020-2027, (USD Million)

Table 17 India Skin Cancer Market by Types, 2020-2027, (USD Million)

Table 18 India Skin Cancer Market by Treatment, 2020-2027, (USD Million)

Table 19 India Skin Cancer Market by End Users, 2020-2027, (USD Million)

Table 20 Republic of Korea Skin Cancer Market by Types, 2020-2027, (USD Million)

Table 21 Republic of Korea Skin Cancer Market by Treatment, 2020-2027, (USD Million)

Table 22 Republic of Korea Skin Cancer Market by End Users, 2020-2027, (USD Million)

Table 23 Rest of Asia Pacific Skin Cancer Market by Types, 2020-2027, (USD Million)

Table 24 Rest of Asia Pacific Skin Cancer Market by Treatment, 2020-2027, (USD Million)

Table 25 Rest of Asia Pacific Skin Cancer Market by End Users, 2020-2027, (USD Million)

 

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Asia Pacific Skin Cancer Market

Figure 3 Segmentation Market Dynamics for Skin Cancer Market

Figure 4 Asia Pacific Skin Cancer Market Share, by Types 2020

Figure 5 Asia Pacific Skin Cancer Market Share, by Treatment 2020

Figure 6 Asia Pacific Skin Cancer Market Share, by End Users, 2020

Figure 7 Asia Pacific Skin Cancer Market Share, by Region, 2020

Figure 8 Asia Pacific Skin Cancer Market: Company Share Analysis, 2020 (%)

Figure 9 F. Hoffmann-La Roche Ltd: Key Financials

Figure 10 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 11 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 12 Novartis International AG: Key Financials

Figure 13 Novartis International AG: Segmental Revenue

Figure 14 Novartis International AG: Geographical Revenue

Figure 15 Sun Pharma Industries Ltd.: Key Financials

Figure 16 Sun Pharma Industries Ltd.: Segmental Revenue

Figure 17 Sun Pharma Industries Ltd.: Geographical Revenue

Figure 18 Elekta AB: Key Financials

Figure 19 Elekta AB: Segmental Revenue

Figure 20 Elekta AB: Geographical Revenue

Figure 21 Varian Medical Systems Inc: Key Financials

Figure 22 Varian Medical Systems Inc: Segmental Revenue

Figure 23 Varian Medical Systems Inc: Geographical Revenue

Figure 24 Eli Lilly and Co.: Key Financials

Figure 25 Eli Lilly and Co.: Segmental Revenue

Figure 26 Eli Lilly and Co.: Geographical Revenue

Figure 27 Bristol Myers Squibb: Key Financials

Figure 28 Bristol Myers Squibb: Segmental Revenue

Figure 29 Bristol Myers Squibb: Geographical Revenue

Figure 30 Leo Pharma A/S: Key Financials

Figure 31 Leo Pharma A/S: Segmental Revenue

Figure 32 Leo Pharma A/S: Geographical Revenue